Protagonist Therapeutics
PTGX
$26.09
Share price
2.15%
Change (1 day)
10.55%
Change (1 year)
Categories
EPS for Protagonist Therapeutics (PTGX)
EPS in 2023 (TTM): -$2.68
According to Protagonist Therapeutics 's latest financial reports the company's current EPS (TTM) is -$2.68. In 2022 the company made an earnings per share (EPS) of -$2.60 an increase over its 2021 EPS that were of -$2.70.
EPS history for Protagonist Therapeutics from 2015 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$2.68 | 3.08% |
| 2022 | -$2.60 | -3.7% |
| 2021 | -$2.70 | 35% |
| 2020 | -$2.00 | -33.33% |
| 2019 | -$3.00 | 74.42% |
| 2018 | -$1.72 | -20.74% |
| 2017 | -$2.17 | -45.64% |
| 2016 | -$3.99 | 57.3% |
| 2015 | -$2.54 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | -18.66% | 🇺🇸 USA |